Diabetes requiring insulin tied to increased stroke risk in A-fib

January 26, 2017

(HealthDay)—For patients with atrial fibrillation (AF), diabetes requiring insulin, but not diabetes without insulin treatment, is associated with an increased risk of stroke/systemic embolism, according to a study published in the Jan. 31 issue of the Journal of the American College of Cardiology.

Giuseppe Patti, M.D., from the Campus Bio-Medico University of Rome, and colleagues examined the differential role of insulin versus no on thromboembolic risk in a cohort of with AF. The authors compared the rates of stroke/systemic embolism at one year according to status. Data were included for 5,717 patients; 1,288 of these had diabetes, of whom 22.4 percent were on insulin.

The researchers found that the risk of stroke/systemic embolism at one year was increased for patients with diabetes who were on insulin, compared to those without diabetes (5.2 versus 1.9 percent; hazard ratio, 2.89; 95 percent confidence interval, 1.67 to 5.02; P = 0.0002) or those with diabetes without (5.2 versus 1.8 percent; hazard ratio, 2.96; 95 percent confidence interval, 1.49 to 5.87; P = 0.0019). Similar rates of stroke/embolism were seen for patients with diabetes not receiving insulin and for patients without diabetes (hazard ratio, 0.97; 95 percent confidence interval, 0.58 to 1.61; P = 0.90).

"In this cohort of anticoagulated patients with AF, the sole presence of diabetes not requiring insulin did not imply an increased thromboembolic risk," the authors write. "Conversely, -requiring diabetes contributed most, if not exclusively, to the overall increase of thromboembolic risk in AF."

Several authors disclosed financial ties to the pharmaceutical industry.

Explore further: Long-acting analog insulin doesn't up AMI risk in T2DM

More information: Full Text
Editorial

Related Stories

Long-acting analog insulin doesn't up AMI risk in T2DM

August 20, 2015
(HealthDay)—For patients with type 2 diabetes, the risk of acute myocardial infarction (AMI) is not significantly different for long-acting insulin analogs versus other basal insulin therapies, according to a study published ...

Lowest glucose variability for insulin + GLP-1 RA in T2DM

December 20, 2016
(HealthDay)—For patients with type 2 diabetes, the lowest glucose variability (GV) and hypoglycemia is seen for patients using basal insulin + glucagon-like peptide 1 receptor agonist (GLP-1 RA) (BGLP), according to a study ...

Fenofibrate may reduce CVD in patients with DM, dyslipidemia

January 4, 2017
(HealthDay)—Fenofibrate therapy may reduce cardiovascular disease (CVD) in statin-treated patients with diabetes and dyslipidemia, according to a study published online Dec. 28 in JAMA Cardiology.

CVD risk similar for metformin + insulin or sulfonylureas

July 20, 2015
(HealthDay)—For patients with type 2 diabetes, the risk of myocardial infarction (MI) or stroke is similar for treatment with insulin or sulfonylureas in combination with metformin, according to a study published online ...

HOMA2-IR tied to hepatocellular carcinoma risk in hepatitis B

November 19, 2016
(HealthDay)—Insulin resistance assessed by homeostasis model assessment index (HOMA2-IR) correlates with the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV) infection, according to ...

Sitagliptin not linked to higher fracture risk in diabetes

September 14, 2016
(HealthDay)—Patients with diabetes often have fractures, but sitagliptin is not associated with increased fracture risk, according to a study published online Sept. 8 in Diabetes, Obesity and Metabolism.

Recommended for you

Getting fat to 'talk' again could lower blood glucose and weight

August 22, 2017
Diabetes is a tough disease to manage. Oral medications, insulin shots, close monitoring of blood sugar, dietary changes and exercise can all factor into a person's treatment regimen. Now researchers are exploring a novel, ...

New molecule may hold the key to triggering the regeneration and repair of damaged heart cells

August 21, 2017
New research has discovered a potential means to trigger damaged heart cells to self-heal. The discovery could lead to groundbreaking forms of treatment for heart diseases. For the first time, researchers have identified ...

Biochemical 'fingerprints' reveal diabetes progression

August 21, 2017
Researchers from Umeå University in Sweden describe a new method to study biochemical changes that occur in the pancreas during the development of diabetes. The method, recently published in Scientific Reports, is based ...

Researchers investigate the potential of spider silk protein for engineering artificial heart

August 18, 2017
Ever more people are suffering from cardiac insufficiency, despite significant advances in preventing and minimising damage to the heart. The main cause of reduced cardiac functionality lies in the irreversible loss of cardiac ...

Lasers used to detect risk of heart attack and stroke

August 18, 2017
Patients at risk of heart attacks and strokes may be spotted earlier thanks to a diagnosis tool that uses near-infrared light to identify high-risk arterial plaques, according to research carried out at WMG, University of ...

In a nutshell: Walnuts activate brain region involved in appetite control

August 17, 2017
Packed with nutrients linked to better health, walnuts are also thought to discourage overeating by promoting feelings of fullness. Now, in a new brain imaging study, researchers at Beth Israel Deaconess Medical Center (BIDMC) ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.